OTC Drug Packaging Should Fit Labeling, FDA's Ganley Says
This article was originally published in The Rose Sheet
Executive Summary
OTC drug manufacturers should tailor product packaging to fit the labeling required under FDA's final rule rather than "chop away at the labeling rule to make it fit onto the package," Division of OTC Drugs Director Charles Ganley, MD, told industry reps at a working group meeting in Rockville, Md. Nov. 23.
You may also be interested in...
OTC Labeling Trade Dress Issue Resolved In FDA Technical Amendment
Labeling of over-the-counter drug products may include light type on a dark background providing the combination results in a highly readable contrast, FDA asserts in a technical amendment to the OTC label reform rule published in the Jan. 3 Federal Register.
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program